IRV Lab Exhaust and Vacuum Pump Replacement

SOL #: OC-2026-131276Sources Sought

Overview

Buyer

Health And Human Services
Food And Drug Administration
FDA OFFICE OF ACQ GRANT SVCS
Beltsville, MD, 20705, United States

Place of Performance

Irvine, CA

NAICS

Plumbing (238220)

PSC

Repair Or Alteration Of Office Buildings (Z2AA)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 2, 2026
2
Response Deadline
Feb 18, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Food and Drug Administration (FDA) is conducting market research through a Sources Sought Notice for the IRV Lab Exhaust and Vacuum Pump Replacement project at its facility in Irvine, California. This is to identify qualified firms, assess industry capabilities, and determine potential set-aside considerations for a future FAR Part 36 construction requirement. Responses are due by February 18, 2026, at 5:00 PM PST.

Purpose

This Sources Sought Notice is issued solely for market research purposes in accordance with FAR Part 10. It is not a solicitation or request for proposals. The Government seeks information from qualified small businesses to assess their availability, capability, and potential for set-aside considerations for this construction requirement. Information gathered will support acquisition strategy development, evaluate commercial availability, and assess small business participation.

Scope of Requirement

The anticipated requirement involves the removal, purchase, delivery, installation, and commissioning of exhaust and vacuum pump systems for FDA laboratory operations in Irvine, CA, specifically targeting Room 2309. The scope includes:

  • Replacement of obsolete vacuum pump systems (e.g., AES-Dekker Laboratory Vacuum System Model AES-VMX0153MA2-45-DS) with new equipment of matching or better capacity, incorporating N+1 redundancy.
  • Correction of VHP detection alarms by directly ducting isolators to the outside via an exhaust fan.
  • Selective demolition and removal of existing HVAC/exhaust components.
  • Installation and integration with existing building infrastructure, automation, and controls, including a new control panel integrated with the existing Building Automation System (BAS).
  • Utilization of commercially available exhaust and/or vacuum pump units, with materials like UV-stable plastic or 316L Stainless Steel ducting specified for corrosion resistance.
  • Testing, adjusting, balancing (TAB), commissioning, and acceptance, adhering to NIH Design Requirements Manual (DRM), Section 12.4.
  • Coordination of all work to minimize disruption to ongoing FDA operations, with disruptive work preferably performed during Government unoccupied hours.
  • Compliance with local, State, and Federal codes, including strict environmental controls, waste management (50% diversion goal), and safety protocols (Site-specific Construction Safety and Health Plan).

Requested Information

Interested parties must complete and submit the provided vendor questionnaire (.xlsx format) addressing:

  • Business Information: Company details, UEI, CAGE Code, business size, socioeconomic status, applicable NAICS codes.
  • Technical Capability: Description of offered exhaust/vacuum pump products (COTS preferred), manufacturer, performance specifications, and compliance with codes (OSHA, NFPA, ASME, ISO, EPA).
  • Installation and Integration: Experience with HVAC/exhaust systems in occupied laboratory/healthcare facilities, capability to perform FAR Part 36 construction requirements.
  • Schedule and Risk Considerations: Identification of key schedule risks and estimated equipment lead times.
  • Financial Capability: Average annual construction revenue, ability to obtain performance/payment bonds, insurance, and upfront financing.
  • Past Performance: Two (2) similar projects within the last five (5) years.
  • Commerciality: Market availability, lead times, and country of origin for proposed products.

Submission Instructions

Responses must be submitted electronically in .xlsx format to Sheneil Green (sheneil.green@fda.hhs.gov). The email subject line must be: "FDA IRV Exhaust and Vacuum Source Sought Response – [Company Name]". Attachments should be limited to product cutsheets or brochures supporting questionnaire responses.

Key Dates

  • Response Due: February 18, 2026, 5:00 PM PST
  • Published: February 2, 2026

Additional Notes

This notice is for information and planning purposes only and does not constitute a commitment by the Government. The Government will not pay for information submitted.

People

Points of Contact

Files

Files

Download
Download
Download
Download

Versions

Version 1Viewing
Sources Sought
Posted: Feb 2, 2026
IRV Lab Exhaust and Vacuum Pump Replacement | GovScope